Delivery Order SPE2DR25D2005-SPE2DR26FE8N1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $15,747.50 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials. This firm fixed price contract, awarded on November 20, 2025, with an ultimate completion date of November 21, 2025, represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency has awarded a delivery order valued at $37,827.70 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed price contract involves no set-aside designation and carries an ultimate completion date of November 18, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading...
- The Defense Logistics Agency awarded a delivery order valued at $32,613.81 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) in 3 ml quantities. This firm fixed price, competitively awarded contract was issued on December 16, 2025, with an ultimate completion date of December 17, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,004.33 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. This competitive award, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed-price transaction with no set-aside designation. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters and a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $91,757.94 for Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The order represents a single pharmaceutical supply transaction under...
- The Defense Logistics Agency awarded a $11,867.82 delivery order to AmerisourceBergen Drug Corp for Ozempic 2 mg/dose (8 mg/3 mL) 3 mL vials on November 25, 2025, with a completion date of November 26, 2025. This competitively awarded, firm fixed-price delivery order represents a single-line pharmaceutical supply transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $10,712.92 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) pre-filled pens on August 18, 2025, with completion expected by August 19, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $14,891.23 delivery order to AmerisourceBergen Drug Corp for Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials, with a completion date of November 13, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical product requisition under the agency's medical supply procurement operations. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,715.82 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price contract was issued on November 18, 2025, with an ultimate completion date of November 19, 2025. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $11,291.22 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of July 15, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE8N1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $17,177.13 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price delivery order was issued on December 10, 2025, with an ultimate completion date of December 11, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement and supplies medications and medical supplies across multiple therapeutic domains to support military healthcare systems, the Defense Health Agency, the U.S. Coast Guard, and other government healthcare organizations. The company's federal contract portfolio demonstrates consistent capability to meet competitive procurement requirements through open competition across a wide range of pharmaceutical products and delivery scales.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.2k | 12/9/25 |